Urolase Ltd

Urolase Ltd, based in Liverpool, UK, is a small, active company founded seven years ago. With just two employees and £198,973 in assets, it operates from a virtual address – a detail flagged by the registration of twenty companies at the same location. The company is led by a solo founder and director, Jenkinso Ross, and imports optical and medical tools and devices, though irregularly, with the last import occurring just one month ago.

The company's website reveals a specialized business model: Urolase Holmium Laser Hire. Rather than selling lasers, they provide rental services to hospitals, offering state-of-the-art technology and experienced technicians to avoid the large capital expenditure associated with outright purchase. They specialize in HoLEP, ThuFLEP, stone treatment, and tumour ablation, even partnering with Echo Laser for microinvasive prostate treatment. Testimonials from established urologists highlight their reliability, flexibility, and expertise.

Financially, Urolase Ltd presents a mixed picture. While cash reserves increased by 9.7% to £110,000, current assets decreased by 14% to £200,000. Bank borrowings decreased, but a significant drop in equity—8.1%—to £210,000 raises questions about the company's long-term financial health. Trade debtors decreased by 24%, which could indicate better debt collection, but the decrease in net assets is a concern. The company’s small size (meeting two of three criteria for a small company) allows for agility, but the equity decline warrants closer scrutiny. As a small company, Urolase Ltd is exempt from an audit, so the financial data is unaudited.

Overall, Urolase Ltd seems to be navigating a competitive market by offering a valuable service—laser rental—but the recent financial trends suggest it’s facing some challenges.

Registered in England/Wales under the registration number 11163934, with a registered address at L2 5QQ, United Kingdom, Liverpool, Pacific Chambers, 11-13 Victoria Street.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.